Business Description
Onconic Therapeutics is a South Korean pharmaceutical company focused on developing new treatments for cancer and digestive diseases. Founded in 2020 and headquartered in Seoul, the company is advancing several drug candidates, including a stomach acid treatment currently in late-stage clinical trials and a pancreatic cancer drug in early-stage testing. Its broader research efforts also target the body's DNA repair pathways and the use of the immune system to fight cancer.
